MRX34
= MRX34
{c}
A liposomal miR-34a <microRNA mimic> studied in a phase 1 trial. Serious immune-related toxicity illustrates limits of inferring therapeutic safety from endogenous regulatory function.<Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours by David S. Hong and others>[Trial safety findings]{ref}